EuroQuity Blog

Join the InvestHorizon e-pitch Session Healthtech on October the 20th at 5:00pm

Our next InvestHorizon pitch session organized by META will be held online on October the 20th at 5:00 PM CEST.
6 Healthtech companies will be presented.
All these Serie A companies are part of the European InvestHorizon acceleration program, and are looking for funds to continue their growth.

Here is the list of the 6 deeptech companies:

Digital Health/Medical devices – A neurostimulation device to delay dementia onset 
Spin-off of a leading Spanish university in neurotechnology research. The startup has developed a neurostimulation device that increases cognitive function by 25% in 8 hours, and obtains 2.5 times more effects in 4.2 times less time than any other alternative. The treatment has been successfully followed by 250+ people in 2,500+ sessions through the main Spanish healthcare groups. 
15+ clients | TRL 6 | TAM: 3.5bn |CAGR 2020-2027: 17,5% | Next steps: clinical trial and industrialization | Amount to raise: 2M€ - Spain

BIOMIMESYS, a groundbreaking technology, is the only organ-specific microenvironment that allows to recreate in vitro organs, healthy or cancerous. With BIOMIMESYS technology, success to find new drugs against cancer will shift from 7% to 93% and we will find new effective drug against microenvironment modification, the cause of cancer initiation and progression. Recognised "Deep Tech Pioneer" by Hello Tomorrow Global Challenge 2020; awarded by Forum Labo as a disruptive technology and by Start West jury of investors; one of 10 finalists of the Female Founder Challenge organized by Viva Technology ; selected in Invest Horizon coaching programme; 8 MTA/MOU and 16 LOIs signed by pharmaceutical industries/CROs (Sanofi, Servier, Evotec) and academic research units | Amount to raise: 3.5M€  – France 

Medtech/Real World Imaging Evidence – Unleashing Medical Imaging to deliver real world Evidence to Biopharma thanks our Network of European Hospitals & Partners.  
Spin-off project from a University Hospital, the start-up has developed the Medexprim Suite which allow the Extraction, the Curation, the Enrichment & the De-Identification of multi-centric and complex Dataset for Biopharma. The first software solution, already in use in 30 Hospitals all over Europe, allow tailored GDPR compliant Dataset extractions to train AI model, to build Imaging Biomarkers, to identify patients and develop synthetic control arms. A Smart Contractive and Federative platform is planned in order to deliver Evidence thanks to sophisticated processing and analytics tools. Main customers : Biopharma : TRL : 6 (R-WiDE Platform), TRL : 9 (Medexprim Suite™) | TAM : €1.2bn  Amount to raise: €5M - France

Medtech / Wearable / AI / Autonomic Dysfunction - Theraupatic non-invasive wearable platform technology for the autonomic nervous system dysfunction caused diseases. 
A spin-off startup from the Faculty of Health Sciences at Bahcesehir University develops wearable and connected non-invasive auricular vagus nerve stimulation device. The technology developed aims to solve diseases such as migraine and hyper inflammation triggered by the autonomic nervous system dysfunction which can be defined as an increase in sympathetic and suppress parasympathetic nervous system activities. 2 patent applications are filled, and the proof of concept studies is completed. Research-only device sales for B2B customers are started. Main customers: B2C: Patients suffer from headaches, chronic pains, and hyper-inflammation, B2B: Neuromodulation Researchers | TRL:7 | TAM: €4bn | Amount to raise: 1.5M€ - Turkey  

Health tech / Gynecology diagnostics  
Presenting the first ML / AI based multi-causal, rapid, cost effective and accurate point of care diagnostic system for Vaginitis, a very common gynecology condition that is misdiagnosed today in 50% of clinic visits. Granted three times by IIA, ISO13485 certified, CE marked, Pilots in place, H2020 seal of excellence. | Amount to raise: 5M€ – Israel 

Consumer Electronics / Hearables / Hearing Aids / Micro Speaker / Semiconductors -Revelutional High Quality Miniature Speaker 
Multi patented technology based on providing sound from modulated ultrasound. Providing fidelity sounds tenfold in size than other microspeakers. The speaker is based on a MEMS chip, which currently we have samples demonstrating the quality. Working on new generations that will demonstrate the full functionality of the speaker. 
3 Patents world wide; LOIs from customers / TRL: 6 / TAM: $12bn / Next step: Commercialization| Amount to raise: 3M€

Rédigé par Valentin Marin le Tuesday, October 13th 2020
Stay informed by suscribing to our newsletter